- Home
- BREA vs CNSP Comparison
BREA vs CNSP Comparison
Compare BREA & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BREA
- CNSP
- Stock Information
- Founded
- BREA 2022
- CNSP 2017
- Country
- BREA Ireland
- CNSP United States
- Employees
- BREA N/A
- CNSP N/A
- Industry
- BREA Services-Misc. Amusement & Recreation
- CNSP Biotechnology: Pharmaceutical Preparations
- Sector
- BREA Consumer Discretionary
- CNSP Health Care
- Exchange
- BREA Nasdaq
- CNSP Nasdaq
- Market Cap
- BREA 8.7M
- CNSP 6.5M
- IPO Year
- BREA 2023
- CNSP 2019
- Fundamental
- Price
- BREA $0.66
- CNSP $2.50
- Analyst Decision
- BREA
- CNSP Strong Buy
- Analyst Count
- BREA 0
- CNSP 1
- Target Price
- BREA N/A
- CNSP $25.00
- AVG Volume (30 Days)
- BREA 4.3M
- CNSP 1.1M
- Earning Date
- BREA 01-03-2025
- CNSP 03-31-2025
- Dividend Yield
- BREA N/A
- CNSP N/A
- EPS Growth
- BREA N/A
- CNSP N/A
- EPS
- BREA N/A
- CNSP N/A
- Revenue
- BREA $2,872,101.00
- CNSP N/A
- Revenue This Year
- BREA N/A
- CNSP N/A
- Revenue Next Year
- BREA N/A
- CNSP N/A
- P/E Ratio
- BREA N/A
- CNSP N/A
- Revenue Growth
- BREA 2338.69
- CNSP N/A
- 52 Week Low
- BREA $0.50
- CNSP $2.00
- 52 Week High
- BREA $1.95
- CNSP $1,150.00
- Technical
- Relative Strength Index (RSI)
- BREA 49.12
- CNSP 35.88
- Support Level
- BREA $0.60
- CNSP $2.00
- Resistance Level
- BREA $0.77
- CNSP $3.03
- Average True Range (ATR)
- BREA 0.11
- CNSP 0.43
- MACD
- BREA 0.01
- CNSP -0.01
- Stochastic Oscillator
- BREA 10.76
- CNSP 21.28
About BREA Brera Holdings PLC
Brera Holdings PLC focused on expanding social impact football by developing a international portfolio of emerging football clubs with increased opportunities to earn tournament prizes, gain sponsorships, and provide other professional football and related consulting services.
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.